Recombinant Fibrinogen Like Protein 1 (FGL1)

FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1

  • Product No.RPD022Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass40.7KDa
  • Accurate Molecular Mass41kDa(Analysis of differences refer to the manual)
  • Residues & TagsLeu23~Ile312 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL.
  • Traits Freeze-dried powder
  • Purity> 90%
  • Isoelectric Point5.5
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 168  US$ 420  US$ 840  US$ 2520  US$ 6300 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
J Hepatol. The role of Hepassocin in the development of non-alcoholic fatty liver disease Pubmed: 23792031
Diabetes Management Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease Futuremedicine:Source
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer y2016:0077095.html
Cell Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC Doi: 10.1016/j.cell.2018.09.053
Liver Research Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus?
Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APD022Hu61 Active Fibrinogen Like Protein 1 (FGL1) Cell culture; Activity Assays.
EPD022Hu41 Eukaryotic Fibrinogen Like Protein 1 (FGL1) Positive Control; Immunogen; SDS-PAGE; WB.
EPD022Hu62 Eukaryotic Fibrinogen Like Protein 1 (FGL1) Positive Control; Immunogen; SDS-PAGE; WB.
RPD022Hu01 Recombinant Fibrinogen Like Protein 1 (FGL1) Positive Control; Immunogen; SDS-PAGE; WB.
PAD022Hu01 Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB,IHC
LAD022Hu71 Biotin-Linked Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC.
LAD022Hu81 FITC-Linked Polyclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC; IF.
MAD022Hu22 Monoclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC; IP.
MAD022Hu23 Monoclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC; ICC; IP.
MAD022Hu24 Monoclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB
MAD022Hu21 Monoclonal Antibody to Fibrinogen Like Protein 1 (FGL1) WB; IHC
SED022Hu ELISA Kit for Fibrinogen Like Protein 1 (FGL1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMD022Hu Multiplex Assay Kit for Fibrinogen Like Protein 1 (FGL1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSD022Hu01 ELISA Kit DIY Materials for Fibrinogen Like Protein 1 (FGL1) Main materials for "Do It (ELISA Kit) Yourself".